See the panel discussion on how innovative neutral arenas are central to the development of the smart and knowledge-intensive city. Flemingsberg Science CEO Johnny Högberg participates together with a panel consisting of Sophia Sundberg, CEO, Barkaby Science, Peter Dobers, Professor of Business Administration with a focus on sustainable development and collaboration, Södertörn University, Johan Zachrisson, Business Development Manager, Fabege and Anton Västberg, Development Director, Region Stockholm.

STARTUP is a competition for startups with a clear connection to Flemingsberg, either as students, residents or otherwise active in the area. All ideas are welcome to participate in STARTUP as long as you compete with your own idea and the turnover and external equity is below SEK 1,000,000 at the time you submit to the competition. After that, we of course welcome you to continue working with the business idea, sales and any investments.

After 10 years as a start-up, CellProtect Nordic Pharmaceuticals has taken a major step forward. Our patient and careful work is now bearing fruit, explains Karin Mellström, CEO and founder. Looking back on her career, she sums it up by saying: “I’d never been bored for a second!”

During the course of the pandemic, he has appeared on an almost daily basis in the morning papers or on the TV news. Matti Sällberg fast became an expert the media called for help explaining everything from vaccine development to the spread of infection.

Nearly 100,000 people in Sweden suffer from Alzheimer’s. Globally, about 30 million people are thought to have the disease. There is still no cure, but research is approaching a point where new drugs may become crucial. AlzeCure is one of the pharmaceutical companies that has made the most progress.